| Trial Identifier: | D7260C00007 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Parexel
|
| Start Date: | May 2025 |
| Primary Completion Date: | February 2026 |
| Study Completion Date: | February 2026 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| DE | Berlin, DE, 14050 |
| US, MD | Baltimore, MD, US, 21225 |